Regenerative tissue.

Aroa has developed a regenerative tissue platform that is being commercialised in the US market through two significant international partnerships. The company has a novel patent portfolio, FDA clearance for its products, and has built an internationally experienced management team and Board.

Movac invested to build a world class manufacturing facility in Auckland, complete the development of new products, and fund growth.

Recent Insights